Alpine Partners VI »

Iovance Biotherapeutics shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $113k 14k 8.02
2021-12-31 $674k 35k 19.10

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Microstrategy Cl A New (MSTR)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Microsoft Corporation (MSFT)
Live Nation Entertainment In Note 2.000% 2/1
Rivian Automotive Note 4.625% 3/1
Vishay Intertechnology Note 2.250% 6/1
Veeco Instrs Inc Del Note 2.875% 6/0
Alphabet Cap Stk Cl A (GOOGL)
Snap Note 0.125% 3/0
Burlington Stores Note 2.250% 4/1
Ncl Corp Note 5.375% 8/0

View all positions for Alpine Partners VI

Top funds holding Iovance Biotherapeutics

Perceptive Advisors
Vanguard Group
MHR Fund Management
BlackRock
BlackRock
State Street Corporation
Soleus Capital Management
T. Rowe Price Investment Management
Geode Capital Management
Artisan Partners Limited Partnership
Balyasny Asset Management
Long Focus Capital Management
Principal Financial Group
T. Rowe Price Associates
Palo Alto Investors

View all funds holding Iovance Biotherapeutics